Relationships between Breast Feeding and Breast Cancer Subtypes: Lessons Learned from Studies in Humans and in Mice

被引:25
|
作者
Ambrosone, Christine B. [1 ]
Higgins, Michael J. [2 ]
机构
[1] Roswell Park Comprehens Canc Ctr, Dept Canc Prevent & Control, Buffalo, NY USA
[2] Roswell Park Comprehens Canc Ctr, Dept Cellular & Mol Biol, Buffalo, NY USA
关键词
MAMMARY-GLAND DEVELOPMENT; AFRICAN-AMERICAN WOMEN; GENE-EXPRESSION; REPRODUCTIVE FACTORS; RECEPTOR STATUS; RISK-FACTORS; METHYLATION; PREGNANCY; PARITY; FOXA1;
D O I
10.1158/0008-5472.CAN-20-0077
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There are differential risk relationships between parity and breast cancer according to estrogen receptor (ER) status, with an increased risk of ER- disease reduced by breastfeeding. This may be particularly relevant for understanding the higher incidence of ER- tumors in Black women, who are more likely to be parous and less likely to breastfeed than other U.S. groups. Potential mechanisms for these relationships may include effects of disordered breast involution on inflammatory milieu in the breast as well as epigenetic reprogramming in the mammary gland, which can affect cell fate decisions in progenitor cell pools. In normal breast tissue, parity has been associated with hypermethylation of FOXA1, a pioneer transcription factor that promotes the luminal phenotype in luminal progenitors, while repressing the basal phenotype. In breast tumors, relationships between FOXA1 methylation and parity were strongest among women who did not breastfeed. Here, we summarize the epidemiologic literature regarding parity, breastfeeding, and breast cancer subtypes, and review potential mechanisms whereby these factors may influence breast carcinogenesis, with a focus on effects on progenitor cell pools in the mammary gland.
引用
收藏
页码:4871 / 4877
页数:7
相关论文
共 50 条
  • [21] Relationship Between Breast Density, Breast Cancer Subtypes, and Prognosis
    Yamada, Daisuke
    Ohde, Sachiko
    Kajiura, Yuka
    Yagishita, Kazuyo
    Nozaki, Fumi
    Suzuki, Koyu
    Kanomata, Naoki
    Yamauchi, Hideko
    Tsunoda, Hiroko
    CLINICAL BREAST CANCER, 2022, 22 (06) : 560 - 566
  • [22] Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trial
    Legrand, C
    Duchateau, L
    Sylvester, R
    Janssen, P
    van der Hage, JA
    van de Velde, CJH
    Therasse, P
    CLINICAL TRIALS, 2006, 3 (01) : 10 - 18
  • [23] Cancer lessons from mice to humans
    David Tuveson
    Douglas Hanahan
    Nature, 2011, 471 : 316 - 317
  • [24] BREAST CANCER FROM BREAST-FEEDING
    FRAUMENI, JF
    MILLER, RW
    LANCET, 1971, 2 (7735): : 1196 - &
  • [25] Prostate cancer screening: the problem of overdiagnosis and lessons to be learned from breast cancer screening
    Ciatto, S
    Zappa, M
    Bonardi, R
    Gervasi, G
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) : 1347 - 1350
  • [26] Genetic cardiomyopathies Lessons learned from humans, mice, and zebrafish
    Kloos, W.
    Katus, H. A.
    Meder, B.
    HERZ, 2012, 37 (06) : 612 - 617
  • [27] Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancer
    Eiger, Daniel
    Brandao, Mariana
    de Azambuja, Evandro
    ESMO OPEN, 2020, 5 (02)
  • [28] Providing Breast Cancer Survivorship Lessons Learned From a Pilot Project Implementation
    Johnson, Kathleen J.
    Minchew, Leigh A.
    Richter, Sara
    Craft, Cheryl
    Lerner, Rachel
    CANCER NURSING, 2017, 40 (05) : E51 - E61
  • [29] An evaluation of the Train the Trainer International Breast Health and Breast Cancer Education: Lessons learned
    Karen Dow Meneses
    Connie Henke Yarbro
    Journal of Cancer Education, 2008, 23 : 267 - 271
  • [30] Microarrays in primary breast cancer - lessons from chemotherapy studies
    Lonning, PE
    Sorlie, T
    Perou, CM
    Brown, PO
    Botstein, D
    Borresen-Dale, AL
    ENDOCRINE-RELATED CANCER, 2001, 8 (03) : 259 - 263